Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hjorth

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Physical Review Letters|May 28, 2013
Optimized chiral nucleon-nucleon interaction at next-to-next-to-leading orderA Ekström, G Baardsen, C Forssén, et al.
Diabetologia|December 1, 2010
Extended evaluation of the safety and efficacy of GAD treatment of children and adolescents with recent-onset type 1 diabetes: a randomised controlled trialJ Ludvigsson, M Hjorth, M Chéramy, et al.
Acta Physiologica (Oxford, England)|November 18, 2015
Myostatin in relation to physical activity and dysglycaemia and its effect on energy metabolism in human skeletal muscle cellsM Hjorth, S Pourteymour, S W Görgens, et al.
Journal of Thrombosis and Haemostasis : JTH|April 26, 2006
Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 monthsS Schulman, P Lindmarker, M Holmström, et al.
Physical Review Letters|November 13, 2003
N=82 shell quenching of the classical r-process "waiting-point" nucleus 130CdI Dillmann, K-L Kratz, A Wöhr, et al.
Frontiers in Immunology|April 18, 2022
Intracellular Complement Component 3 Attenuated Ischemia-Reperfusion Injury in the Isolated Buffer-Perfused Mouse Heart and Is Associated With Improved Metabolic HomeostasisM-K Torp, T Ranheim, C Schjalm, et al.
Medical Oncology (Northwood, London, England)|January 10, 2002
Health-related quality of life in multiple myeloma patients receiving high-dose chemotherapy with autologous blood stem-cell supportN Gulbrandsen, F Wisløff, L Brinch, et al.
Marine Environmental Research|June 18, 2013
Toxicity data for modeling impacts of oil components in an Arctic ecosystemG H Olsen, C Klok, A J Hendriks, et al.
Acta Physiologica (Oxford, England)|August 26, 2015
The exercise-regulated myokine chitinase-3-like protein 1 stimulates human myocyte proliferationS W Görgens, M Hjorth, K Eckardt, et al.
Blood|December 23, 1999
Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study. Nordic Myeloma Study GroupS Lenhoff, M Hjorth, E Holmberg, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Physical Review Letters|May 28, 2013
Optimized chiral nucleon-nucleon interaction at next-to-next-to-leading orderA Ekström, G Baardsen, C Forssén, et al.
Diabetologia|December 1, 2010
Extended evaluation of the safety and efficacy of GAD treatment of children and adolescents with recent-onset type 1 diabetes: a randomised controlled trialJ Ludvigsson, M Hjorth, M Chéramy, et al.
Acta Physiologica (Oxford, England)|November 18, 2015
Myostatin in relation to physical activity and dysglycaemia and its effect on energy metabolism in human skeletal muscle cellsM Hjorth, S Pourteymour, S W Görgens, et al.
Journal of Thrombosis and Haemostasis : JTH|April 26, 2006
Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 monthsS Schulman, P Lindmarker, M Holmström, et al.
Physical Review Letters|November 13, 2003
N=82 shell quenching of the classical r-process "waiting-point" nucleus 130CdI Dillmann, K-L Kratz, A Wöhr, et al.
Frontiers in Immunology|April 18, 2022
Intracellular Complement Component 3 Attenuated Ischemia-Reperfusion Injury in the Isolated Buffer-Perfused Mouse Heart and Is Associated With Improved Metabolic HomeostasisM-K Torp, T Ranheim, C Schjalm, et al.
Medical Oncology (Northwood, London, England)|January 10, 2002
Health-related quality of life in multiple myeloma patients receiving high-dose chemotherapy with autologous blood stem-cell supportN Gulbrandsen, F Wisløff, L Brinch, et al.
Marine Environmental Research|June 18, 2013
Toxicity data for modeling impacts of oil components in an Arctic ecosystemG H Olsen, C Klok, A J Hendriks, et al.
Acta Physiologica (Oxford, England)|August 26, 2015
The exercise-regulated myokine chitinase-3-like protein 1 stimulates human myocyte proliferationS W Görgens, M Hjorth, K Eckardt, et al.
Blood|December 23, 1999
Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study. Nordic Myeloma Study GroupS Lenhoff, M Hjorth, E Holmberg, et al.
Pageof 6